Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Middlesex Water
MSEX
$1.08B
| $595K | ﹤0.01% |
9,061
-2,315
| -20% | -$153K |
|
1902
CTS Corp
CTS
$1.77B
| $595K | ﹤0.01% |
13,611
-27
| -0.2% | -$1.09K |
|
1903
DaVita
DVA
$15.2B
| $594K | ﹤0.01% |
5,670
-2,345
| -29% | -$217K |
|
1904
Horace Mann Educators
HMN
$2.08B
| $591K | ﹤0.01% |
18,085
-32
| -0.2% | -$1.03K |
|
1905
Kforce
KFRC
$984M
| $591K | ﹤0.01% |
8,751
-18
| -0.2% | -$1.15K |
|
1906
Pilgrim's Pride
PPC
$6.63B
| $589K | ﹤0.01% |
21,287
-31
| -0.1% | -$789 |
|
1907
Benitec Biopharma
BNTC
$391M
| $589K | ﹤0.01% |
180,399
-25,771
| -12% | -$86K |
|
1908
Enact Holdings
ACT
$6.6B
| $589K | ﹤0.01% |
20,372
-30
| -0.1% | -$837 |
|
1909
Erie Indemnity
ERIE
$12.8B
| $587K | ﹤0.01% |
1,753
-20
| -1% | -$6.01K |
|
1910
Harmonic Inc
HLIT
$1.22B
| $587K | ﹤0.01% |
45,002
-86
| -0.2% | -$919 |
|
1911
The GEO Group
GEO
$4.09B
| $586K | ﹤0.01% |
54,166
-94
| -0.2% | -$898 |
|
1912
Coastal Financial
CCB
$590M
| $581K | ﹤0.01% |
13,106
+920
| +8% | +$38K |
|
1913
Appian
APPN
$1.98B
| $579K | ﹤0.01% |
15,376
-31
| -0.2% | -$1.21K |
|
1914
S&T Bancorp
STBA
$1.86B
| $579K | ﹤0.01% |
17,314
-30
| -0.2% | -$860 |
|
|
EVBG
1915
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $579K | ﹤0.01% |
23,798
-7,131
| -23% | -$154K |
|
1916
ProFrac Holding
ACDC
$671M
| $576K | ﹤0.01% |
67,881
+47,030
| +226% | +$412K |
|
1917
Independent Bank Corp
IBCP
$780M
| $575K | ﹤0.01% |
22,076
+1,376
| +7% | +$29.4K |
|
1918
Karat Packaging
KRT
$784M
| $574K | ﹤0.01% |
+23,100
| New | +$509K |
|
|
BELFB
1919
Bel Fuse Inc Class B
BELFB
$3.86B
| $574K | ﹤0.01% |
8,583
+22
| +0.3% | +$1.18K |
|
1920
Syndax Pharmaceuticals
SNDX
$1.67B
| $572K | ﹤0.01% |
26,447
-39
| -0.1% | -$599 |
|
1921
National Healthcare
NHC
$3.45B
| $570K | ﹤0.01% |
6,160
-10
| -0.2% | -$766 |
|
1922
TriCo Bancshares
TCBK
$1.84B
| $569K | ﹤0.01% |
13,227
-25
| -0.2% | -$897 |
|
1923
Apogee Enterprises
APOG
$822M
| $569K | ﹤0.01% |
10,662
-16
| -0.1% | -$745 |
|
1924
Knight Transportation
KNX
$11.4B
| $569K | ﹤0.01% |
9,866
-117
| -1% | -$6.13K |
|
|
MODN
1925
DELISTED
MODEL N, INC.
MODN
| $567K | ﹤0.01% |
21,068
-6,229
| -23% | -$150K |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.